Advancement in Vaccination Against Newcastle Disease: Recombinant HVT NDV Provides High Clinical Protection and Reduces Challenge Virus Shedding with the Absence of Vaccine Reactions

V Palya; I Kiss; T Tatár-Kis; T Mató; B Felföldi; Y Gardin

doi:10.1637/10095-993512-DIGEST.1

We can help you reset your password using the email address linked to your BioOne Complete account.

Registered users receive a variety of benefits including the ability to customize email alerts, create favorite journals list, and save searches. Please note that a BioOne web account does not automatically grant access to full-text content. An institutional or society member subscription is required to view non-Open Access content. Contact helpdesk@bioone.org with any questions.

All Fields are Required

First Name

Last/Family Name

Password

Password Requirements: Minimum 8 characters, must include as least one uppercase, one lowercase letter, and one number or permitted symbol Valid Symbols for password:
~ Tilde
! Exclamation Mark
@ At sign
$ Dollar sign
^ Caret
( Opening Parenthesis
) Closing Parenthesis
_ Underscore
. Period

Confirm Password

Web Account created successfully

V Palya, I Kiss, T Tatár-Kis, T Mató, B Felföldi, Y Gardin

No abstract for this paper is available.

American Association of Avian Pathologists, Inc.

Citation Download Citation

V Palya, I Kiss, T Tatár-Kis, T Mató, B Felföldi, and Y Gardin "Advancement in Vaccination Against Newcastle Disease: Recombinant HVT NDV Provides High Clinical Protection and Reduces Challenge Virus Shedding with the Absence of Vaccine Reactions," Avian Diseases Digest 7(2), (1 June 2012). https://doi.org/10.1637/10095-993512-DIGEST.1

Published: 1 June 2012